X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (378) 378
humans (375) 375
oncology (267) 267
male (263) 263
cancer (208) 208
middle aged (202) 202
aged (199) 199
female (185) 185
urology & nephrology (155) 155
carcinoma, renal cell - drug therapy (132) 132
kidney neoplasms - drug therapy (129) 129
urology (128) 128
survival (120) 120
care and treatment (108) 108
carcinoma, renal cell (102) 102
sunitinib (100) 100
kidney neoplasms - pathology (99) 99
treatment outcome (99) 99
metastasis (98) 98
article (94) 94
prognosis (94) 94
adult (92) 92
renal cell carcinoma (86) 86
aged, 80 and over (83) 83
antineoplastic agents - therapeutic use (77) 77
risk factors (77) 77
retrospective studies (73) 73
prostate cancer (71) 71
abridged index medicus (66) 66
hematology, oncology and palliative medicine (66) 66
carcinoma, renal cell - pathology (65) 65
interferon-alpha (63) 63
analysis (62) 62
disease-free survival (61) 61
sorafenib (59) 59
tumors (57) 57
carcinoma (56) 56
carcinoma, renal cell - mortality (52) 52
neoplasm metastasis (52) 52
everolimus (51) 51
health aspects (50) 50
kidney neoplasms - mortality (49) 49
targeted therapy (49) 49
therapy (49) 49
kidney cancer (48) 48
research (46) 46
vascular endothelial growth factor (46) 46
bevacizumab (45) 45
neoplasm staging (45) 45
risk (45) 45
carcinoma, renal cell - secondary (44) 44
medical colleges (42) 42
chemotherapy (41) 41
immunotherapy (41) 41
mortality (41) 41
patient outcomes (39) 39
carcinoma, renal cell - genetics (38) 38
kidney neoplasms - genetics (38) 38
patients (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (37) 37
clear cell-type renal cell carcinoma (36) 36
survival analysis (36) 36
trial (36) 36
radical prostatectomy (35) 35
survival rate (35) 35
molecular targeted therapy (34) 34
vascular endothelial growth factor a - antagonists & inhibitors (34) 34
kaplan-meier estimate (33) 33
proportional hazards models (33) 33
prostatic neoplasms - therapy (33) 33
men (32) 32
outcomes (32) 32
indoles - therapeutic use (31) 31
pyrroles - therapeutic use (31) 31
radiotherapy (31) 31
time factors (31) 31
usage (31) 31
mutation (30) 30
risk assessment (30) 30
diagnosis (29) 29
antineoplastic agents - adverse effects (28) 28
drug therapy (28) 28
protein kinase inhibitors - therapeutic use (28) 28
seer program (28) 28
antineoplastic agents (27) 27
double-blind (27) 27
follow-up studies (27) 27
kidney neoplasms - metabolism (27) 27
databases, factual (26) 26
metastases (26) 26
open-label (26) 26
prostatic neoplasms - pathology (26) 26
united states (26) 26
angiogenesis inhibitors - therapeutic use (25) 25
bladder cancer (25) 25
carcinoma, renal cell - metabolism (25) 25
niacinamide - analogs & derivatives (25) 25
pazopanib (25) 25
randomized controlled trials as topic (25) 25
antimitotic agents (24) 24
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, pp. 5 - 15
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biomarkers | Renal cell carcinoma | Prognostic | Predictive
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, p. 5
This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC) may be... 
Biological products industry | Metastasis
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 05/2013, Volume 11, Issue 5, pp. 694 - 697
Seven targeted agents have improved the prognosis of advanced renal cell carcinoma (RCC), but none are effective in the post-nephrectomy adjuvant setting.... 
Molecular Targeted Therapy - adverse effects | Prognosis | Nephrectomy | Humans | Kidney Neoplasms - pathology | Neoadjuvant Therapy | Neoplasm Staging | Kidney Neoplasms - therapy
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 01/2014, Volume 32, Issue 1, pp. 5 - 15
Objectives: This review provides a broad overview of emerging data that provide hope that rational precision medicine for metastatic renal cell carcinoma (RCC)... 
Renal cell carcinoma | Predictive | Biomarkers | Prognostic
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 05/2016, Volume 13, Issue 5, pp. 246 - 247
Recurrences can occur in up to 30% of surgically managed patients with localized renal cell carcinoma. Existing uro-oncological guidelines differ in... 
Care and treatment | Relapse | Prognosis | Carcinoma, Renal cell | Research | Risk factors | Cancer
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 9, pp. 889 - 890
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 2015, Volume 13, Issue 5, pp. 327 - 329
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2017, Volume 35, Issue 16, pp. 1859 - 1860
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 11, pp. 1266 - 1267
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 11/2015, Volume 314, Issue 19, pp. 2077 - 2079
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2017, Volume 14, Issue 2, pp. 82 - 84
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1769 - 1770
Journal Article